1. Share Talk

N4 Pharma PLC

15May 2017

N4 Pharma PLC (AIM:N4P) Filing of Patents and Sildenafil Update

 

RNS Number : 0666F

N4 Pharma Plc (AIM: N4P), a specialist pharmaceutical company which reformulates existing drugs and vaccines to improve their performance, is pleased to announce the filing of its Patent Cooperation Treaty (“PCT”) patent application for its sildenafil reformulation and provide an update on the work done by the Company in the year to date as it moves towards clinical trials. In addition, the Company is pleased to announce the filing of two new patents expanding its potential reformulation product pipeline to five.

DON’T MISS OUT!
Subscribe To Our Newsletter
Be the first to get latest updates and exclusive content straight to your email inbox.
Stay Updated
Give it a try, you can unsubscribe anytime.
Get the week’s best articles right in your inbox
Subscribe
Join 15K subscribers